Evidence map›Paper›PMID 30116055›Full record

ReviewJournal of exposure science & environmental epidemiology2019

Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments.

Elaine A Cohen Hubal, Barbara A Wetmore, John F Wambaugh, Hisham El-Masri, Jon R Sobus, Tina Bahadori

Abstract readReview
In one paragraph

Review in Journal of exposure science & environmental epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advancing Toxicity Predictions: A Review onEnvironment & health (Washington, D.C.) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Evaluation of a rapid, generic human gestational dose model.Reproductive toxicology (Elmsford, N.Y.) · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. High-throughput PBTK models forExpert opinion on drug metabolism & toxicology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elaine A Cohen HubalNational Exposure Research Laboratory (NERL), US EPA, Washington, USA. hubal.elaine@epa.gov.
Barbara A WetmoreNational Exposure Research Laboratory (NERL), US EPA, Washington, USA.
John F WambaughNational Center for Computational Toxicology (NCCT), US EPA, Washington, USA.
Hisham El-MasriNational Health and Environmental Effects Laboratory (NHEERL), US EPA, Washington, USA.
Jon R SobusNational Exposure Research Laboratory (NERL), US EPA, Washington, USA.
Tina BahadoriNational Center for Environmental Assessment (NCEA), US EPA, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientifically sound, risk-informed evaluation of chemicals is essential to protecting public health. Systematically leveraging information from exposure, toxicology, and epidemiology studies can provide a holistic understanding of how real-world exposure to chemicals may impact the health of populations, including sensitive and vulnerable individuals and life-stages. Increasingly, public health policy makers are employing toxicokinetic (TK) modeling tools to integrate these data streams and predict potential human health impact. Development of a suite of tools for predicting internal exposure, including physiologically-based toxicokinetic (PBTK) models, is being driven by needs to address large numbers of data-poor chemicals efficiently, translate bioactivity, and mechanistic information from new in vitro test systems, and integrate multiple lines of evidence to enable scientifically sound, risk-informed decisions. New modeling approaches are being designed "fit for purpose" to inform specific decision contexts, with applications ranging from rapid screening of hundreds of chemicals, to improved prediction of risks during sensitive stages of development. New data are being generated experimentally and computationally to support these models. Progress to meet the demand for internal exposure and PBTK modeling tools will require transparent publication of models and data to build credibility in results, as well as opportunities to partner with decision makers to evaluate and build confidence in use of these for improved decisions that promote safe use of chemicals.

Indexed as

Models, BiologicalToxicokineticsEnvironmental ExposureHumansPublic HealthRisk AssessmentToxicologyEpidemiologyExposure modelingPBPK modeling

Identifiers

PMID30116055
PMCPMC6760598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.